Identically, Kumar et al. confirmed that TAK-981 increased the proportions of activated CD8(+) T cells and natural killer (NK) cells through activating STAT1 and IFN target genes, strengthening immune surveillance of tumor cells [197]. Here, CD8A is linked to neoplasm.